Differences in post-exercise inflammatory and glucose regulatory response between sedentary Indigenous Australian and Caucasian men completing a single bout of cycling by Mendham, AE et al.
"This is the peer reviewed version of the following article: Mendham, A. E., Duffield, R., Marino, F. and 
Coutts, A. J. (2014), Differences in post-exercise inflammatory and glucose regulatory response between 
sedentary indigenous Australianand Caucasian men completing a single bout of cycling. Am. J. Hum. 
Biol., 26: 208–214, which has been published in final form at 10.1002/ajhb.22499. This article may be 
used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving." 
1 
 
Article Title:  The post-exercise anti-inflammatory and glucose regulatory response is different 
   between  a sedentary Indigenous Australian and Caucasian cohort completing a single 
   bout of cycle ergometry. 
Running Title: Acute inflammatory and glucose response  
 
Authors:  Mendham, Amy E 
a
., Duffield, Rob 
b
., Marino, Frank 
a
 and Coutts, Aaron J 
b 
 
Institution:   
a 
School of Human Movement Studies,  
    Charles Sturt University,  
 Bathurst, NSW, Australia.  
 
b 
Sport and Exercise Discipline Group, 
UTS: Health, University of Technology Sydney (UTS), 
Sydney, NSW, Australia 
 
Correspondence:   Amy Mendham 
    School of Human Movement Studies 
    Charles Sturt University 
    Panorama Avenue 
    Bathurst, NSW 2795, Australia 
     +61 2 6338 6101 (Telephone) 
     +61 2 6338 4065 (Fax) 
     amendham@csu.edu.au 
 
 
 
 
 
 
 
2 
 
ABSTRACT 
Objectives: This study compared the acute inflammatory and glucose responses following aerobic exercise in 
sedentary Indigenous Australian and Caucasian men, matched for fitness and body composition.  
Methods: Sedentary Indigenous (n=10) and Caucasian (n=9) Australian men who were free from chronic 
disease volunteered to participate. Following baseline testing participants completed a 40min cycle ergometry 
bout at ~80% maximal heart rate. Fasting venous blood was collected pre, 0, 30, 60 min and 240 min post-
exercise for analysis of glucose, insulin, cortisol, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-1 
receptor agonist (ra) and C-reactive protein (CRP).  
Results: Resting TNF-α and glucose concentrations were significantly higher in the Indigenous group (P<0.05). 
IL-6 and IL-1ra were elevated for longer in Caucasian (P<0.05), compared to the Indigenous group (P>0.05). 
The post-exercise (0min) increase in cortisol and glucose for the Caucasians was higher (P<0.05) than the 
attenuated responses within the Indigenous group (P>0.05).  
Conclusions: Despite being matched for fitness and body composition the Indigenous men had elevated resting 
TNF-α and glucose compared to the Caucasian men, which may have contributed to the suppressed post-
exercise anti-inflammatory response of the Indigenous men; however, glucose normalized between groups post-
exercise. As such, it is recommended for acute moderate-intensity exercise to be completed daily for long-term 
improvements in glucose regulation, irrespective of ancestry. Of note, results suggest it to be even more 
pertinent for exercise to be encouraged within the Indigenous Australian population due to their elevated resting 
glucose levels at a younger aged, when compared to the respective Caucasian group. 
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Introduction  
A comparison of physiological characteristics among different ancestral populations can provide insight into the 
disparity in health status between population groups. (Miller and Cappuccio, 2007; Thorburn and others, 1987). 
The worldwide incident rates of type 2 diabetes mellitus (T2DM) has been rising for the past 30 years with 
differences evident between population groups that are specific to ethnicity, geographical location and 
socioeconomic status (Albert, 2007; Cleland and Sattar, 2005; Naqshbandi and others, 2008). Many Indigenous 
groups experience a lower life expectancy consequent to increased prevalence of non-communicable chronic 
diseases (Albert, 2007; Cleland and Sattar, 2005; Welfare, Cat no: IHW 42, 2011). A prominent example of 
population-based differences is observed between Indigenous Australians and their Caucasian counterparts 
(Thorburn and others, 1987; Welfare, Cat no: IHW 42, 2011). As an illustration of this disparity, the age-
standardised rate for Indigenous Australians with diabetes is estimated at 12 %, compared with 4 % for non-
Indigenous Australians (Thomson and others, 2011; Trewin and Madden, 2005; Welfare, Cat no: IHW 42, 
2011). Despite the higher prevalence of diabetes amongst Indigenous Australians, there is little published 
research reporting the acute physiological benefits of physical activity, which is known to be an essential 
component for reducing the potential disease risk in the long-term. 
 
Physical inactivity is well known to influence inflammatory and glucose regulatory mechanisms that contribute 
to the development of T2DM and cardiovascular disease (CVD) (Kahn and others, 2006; Pradhan and others, 
2001). An inverse relationship has been shown between physical activity, excess fat mass and systemic 
inflammatory biomarkers, which are predictors of all-cause mortality (Koenig and others, 2008). Therefore, 
regular physical activity may be an important factor in eliciting favourable acute inflammatory and glucose 
regulatory responses that positively impact on these parameters (Colberg, 2007; Rowley and others, 2000).  
 
The clarification of differences in metabolic and inflammatory parameters enhanced by physical activity would 
be important in establishing whether the disparity in resting metabolic health between Indigenous and Caucasian 
Australians could be positively altered by an acute exercise bout. Therefore, the aim of this study was to 
compare the resting and exercise-induced inflammatory and glucose responses of an acute standardized bout of 
aerobic exercise in middle-aged, sedentary Indigenous Australian and Caucasian men, matched for body 
composition and aerobic fitness.  
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Materials and Methods 
Participant Recruitment 
Participants were recruited from a regional New South Wales community and were men whom self-identified to 
have Australian Indigenous (n=10) or Caucasian (n=9) ancestry. Participants were additionally matched for 
fitness and body composition (Table 1). Prior to data collection, verbal and written consent was provided 
followed by the completion of a pre-exercise health questionnaire and the Medical Outcomes Study Short-Form 
Health Survey (MOS SF-36). The life-expectancy of Indigenous and non-Indigenous Australian men is 67.2 y 
and 78.7 y, respectively (Welfare, Cat no: IHW 42, 2011). Thus, recruitment ensured participants whom 
represented their middle-aged cohort allowing for a ~11.5 y gap between the respective groups (Welfare, Cat 
no: IHW 42, 2011). Participants were sedentary (<1 exercise session per week for <60 min) but not clinically 
diagnosed with any pre-existing CVD or metabolic disorders. Exclusion criteria included: Smokers (< 1 y 
cessation); suffering from recurrent or recent influenza illness (including flu shot recipients); recent surgical 
patients; those on cholesterol lowering, anti-inflammatory, or any other medication reported to affect the 
inflammatory response; rheumatoid arthritis; known or recent periodontal disease. Any participant with a resting 
concentration >10.0 mg·L
1
 for CRP was excluded (Pearson and others, 2003). The study conformed to the 
Declaration of Helsinki and was approved by the Institutional Research in Human Ethics Committee.  
 
Baseline Testing 
Participants completed two sessions separated by a 7 d recovery period. The first session comprised of baseline 
testing, which also acted as an information and familiarisation session to explain all details of the study and 
testing procedures. Anthropometric data were obtained at baseline testing, including stature, body mass, and 
waist and hip girths using standard techniques (Norton and Olds, 1996). Manual blood pressure was obtained by 
aneroid sphygmomanometer and cuff (Welch-Alyn, Arden, North Carolina, USA) expressed as the mean of 
three measurements after the participant had been seated for 5 min. A supine whole body dual-energy x-ray 
absorptiometry (DXA) scan (XR800, Norland, Cooper Surgical Company, USA) was conducted with scanning 
resolution set at 6.5 x 13.0 mm, and scanning speed was set at 260 mm
.
s
-1
. Whole body scans were analysed 
(Illuminatus DXA, ver. 4.2.0, USA) for total body fat mass (TB-FM) and intra-abdominal fat mass (IA-FM) 
(Kim and others, 2002). Analysis of IA-FM was performed with the creation of a region of interest standardized 
across all participants according to previously outlined procedures (Hill and others, 2007).  
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Aerobic capacity measures were obtained via a graded exercise test (GXT) to determine sub-maximal oxygen 
consumption (VO2) and power output (Watts). Prior to each test the metabolic gas analysis system (Parvo 
Medics, True2400, East Sandy, UT, USA) was calibrated and the GXT was performed on an electronically 
braked cycle ergometer (LODE Excalibur Sport, LODE BV, Groningen, The Netherlands) (Mendham et al. 
2011). The test commenced at 25 W and increased by 25 W every min. Participants exercised until attainment of 
80 % age-predicted (220 – age) maximum heart rate (HRmax) to minimise the risks associated with maximal 
physical capacity in potentially higher-risk participants. The last stage completed during the GXT test was 
converted from watts (W) into kilopond (kp) (Colton and Larsen, 2002) and used as the exercise intensity for a 
cadence of 60-65 rpm for the following cycle ergometry session.  
 
Exercise Protocol 
Following an overnight fast (10-12 h), participants arrived at the laboratory (between 0600 and 0800 h) and 
completed an acute bout of cycle ergometry. During all testing procedures the laboratory was at a controlled 
temperature of 18-20 °C. Participants refrained from any physical activity 48 h prior and alcohol and/or caffeine 
consumption 24 h prior to testing. During exercise and for 240 min after all testing sessions, participants 
remained fasted and consumed water ab libitum (~500 mL). The cycling session was conducted on a stationary 
cycle ergometer (Monark 828E, Varburg, Sweden) and comprised of 4 x 10 min efforts, at an intensity of 80 % 
HRmax, interspersed by 2 min passive recovery. Participants maintained a cadence of 60-65 rpm with baseline 
resistance set at the last completed workload of the GXT and (if required) manipulated to maintain the target 
intensity. Heart rate was monitored throughout (Vantage NV, Polar, Finland) and ratings of perceived exertion 
(RPE; Borg’s 6-20 scale) were recorded as a session-RPE 30 min post-exercise (Herman et al. 2006). Of note, 
whilst the current study only involved the participants completing one exercise session, the methodology was 
designed to match an aerobic exercise prescription approach for a sedentary population (Garber and others, 
2011). 
 
Venous Blood Collection 
Prior to the commencement of the protocol participants were cannulated for the collection of venous blood 
samples before and immediately (0 min), 30, 60 and 240 min after exercise (Ostrowski and others, 1999). The 
medial antecubital vein was cannulated and flushed with saline to ensure a clear line. Prior to collecting blood 
for analysis, saline was drawn from the line in another syringe and discarded. During cannulation and all blood 
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draws, participant postural position was standardised in the up-right position. Serum was collected in an SST 
tube for analysis of lipid profile, C-reactive protein (CRP), insulin and cortisol. Plasma was collected in an 
EDTA tube for the analysis of glycosylated haemoglobin (HbA1c), total leukocyte count, interleukin (IL)-6, IL-
1 receptor agonist (ra), IL-1β and tumor necrosis factor (TNF)-α; as well as a fluoride oxalate (FO) tube for 
analysis of glucose. Following the clotting of the sample (SST) or immediately following collection (EDTA, 
FO) samples were centrifuged at 3500 rpm for 15 min at 4°C. Aliquots were frozen immediately at -80°C and -
20°C for EDTA and SST, respectively. Whole blood was refrigerated (4°C) for a maximum of 6 h until analysis 
of total leukocyte count and HbA1c. 
 
Venous Blood Analysis  
Venous blood was also collected for descriptive purposes of the respective populations the following parameters 
were analysed (Maple-Brown and others, 2012). Fasting total cholesterol (Enzymatic method and polychromatic 
endpoint technique), high density lipoprotein (Accelerator selective detergent methodology), low density 
lipoprotein (Friedwald Equation), triglycerides (Enzymatic method and biochromatic endpoint technique) 
(Dimension Xpand Plus, Siemens Healthcare Diagnostics, Sydney, Australia), total leukocyte count (Cell 
counter: Cell-Dyn 3200, Abbott Laboratories, Abbott Park, IL, USA) and HbA1c (High-performance liquid 
chromatography: Bio-Rad Variant, Bio-Rad Laboratories, Sydney, Australia). For the analysis of glucose 
regulatory parameters (Pedersen and Febbraio, 2008; Steensberg and others, 2002), 20 mL was collected at each 
time point for analysis of glucose (ABL825 Flex Analyzer, Radiometer Medical ApS, Bronshoj, Denmark), 
insulin, cortisol (Solid-phase chemiluminescent enzyme immunometric assay: Immulite 2000, Siemens 
Healthcare Diagnostics, Los Angeles, CA, USA). Analysis of biochemistry variables glucose, insulin, cortisol 
and CRP showed intra and inter-assay coefficients of variation between 4.0-7.4 %. For the analysis of 
inflammatory parameters (Ostrowski and others, 1999; Pedersen and Febbraio, 2008), CRP (Particle enhanced 
turbidimetric immunoassay: Dimension Xpand Plus, Siemens Healthcare Diagnostics, Sydney, Australia), IL-6, 
IL-1β, IL-1ra and TNF-α were measured at all-time points (Sandwich enzyme immunoassay ELISA: 
Quantikine, R & D Systems, Minneapolis, MN, USA), with intra and inter-assay coefficients of variation 
between 4.3-5.6 %. As an indication of insulin resistance, Homeostasis Model Assessment (HOMA-IR) was 
calculated based on (fasting insulin x fasting glucose)/22.5 (Matthews and others, 1985). Of note, hematocrit 
was not measured and none of the respective variables have been corrected for plasma volume change. This is a 
potential limitation in the current study, however, procedures were enforced within and between all testing 
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procedures to minimise any potential plasma volume shifts ie. controlled environmental temperature, posture 
collection and standardised fluid consumption prior to, during and following exercise. (Kargotich and others, 
1998).  
 
Statistical Analysis  
All data are reported as mean ± SEM. Within group analysis for all time-points were assessed by a two-way 
repeated measures ANOVA (condition x time). Differences between-groups for all time-points were assessed by 
one-way analysis of variance (ANOVA) with a Tukey’s correction. Significance was accepted at P<0.05. All 
data that were not normally distributed were log transformed prior to analysis. All statistical analyses were 
performed using PASW™ for MS-Windows version 17.0 (Statistical Package for the Social Sciences, Chicago, 
IL, USA).   
 
 
Results  
Resting Venous Blood Chemistry, Body composition and Fitness Variables  
All descriptive measures of anthropometry, DXA (TB-FM %, IA-FM kg), and resting venous blood chemistry 
are presented in Table 1. Both groups were matched for TB-FM % and VO2 (P>0.05); however, the Indigenous 
group was significantly younger and showed higher concentrations of fasting glucose and TNF-α (P<0.05) 
compared to the Caucasians. Aerobic power assessed during baseline testing was reported as the last completed 
stage (W), which did not differ (P=0.52) between Indigenous (183 ± 11 W) and Caucasian groups (172 ± 14 W). 
MOS SF-36 questionnaire results showed no significant difference between groups (P=0.67) with a total of 79.2 
± 5 % for the Indigenous group and 83.9 ± 4 % for the Caucasian group.   
 
Cycle Ergometry Demands 
Resistance for the cycling protocol was not significantly different between groups (P=0.80) at 1.9 ± 0.1 kp for 
Caucasian and 2.0 ± 0.3 kp for the Indigenous group. The mean HR response to the cycling protocol was not 
significantly different (P=0.17) between groups at 81 ± 2 % for Indigenous and 83 ± 1 % HRmax for the 
Caucasian group. Session-RPE was not significantly different between groups (13.9 ± 0.5 and 13.6 ± 0.4 for 
Indigenous and Caucasian groups, respectively; P=0.54).  
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Inflammatory Response to Cycle Ergometry 
The acute post-exercise responses to cycle ergometry for IL-6, IL-1ra, CRP, TNF-α and IL-1β are shown in 
Figure 1. IL-6 exhibited a significant post-exercise increase (P<0.05) for both groups and was not different 
between groups (P=0.63). However, from 30 to 60 min post-exercise IL-6 significantly decreased within the 
Indigenous group (P=0.004), whilst the Caucasian group, remained elevated (P=0.27). IL-1ra was significantly 
elevated post-exercise within both groups (P<0.05), though the Caucasian group showed a sustained elevation of 
IL-1ra above pre values to 240 min post-exercise (P=0.03) that was not evident in the Indigenous group 
(P=0.12). Post-exercise CRP and IL-1β responses did not differ within or between groups (P>0.05). No 
exercise-induced response for TNF-α was evident within either group (P>0.05), whilst between group 
comparisons indicated the Indigenous group to have significantly higher TNF-α values at all time-points 
compared to the Caucasian group (P<0.04).  
 
Cortisol, Glucose and Insulin Response to Cycle Ergometry 
The acute post-exercise response for cortisol, glucose and insulin are shown in Figure 2. Cortisol showed a 
significant increase immediately post-exercise (0 min) within the Caucasian group (P=0.003), but not in the 
Indigenous group (P=0.15). Between group comparisons showed the Caucasian group to have significantly 
elevated cortisol values compared to the Indigenous group at 0 (P=0.008), 30 (P=0.014) and 60 min (P=0.002) 
post-exercise. Glucose responses increased significantly immediately post-exercise within the Caucasian group 
(P=0.01), but not the Indigenous group (P=0.57). The exercise-induced insulin response showed a pre to 240 
min post-exercise decrease within both groups (P<0.05), without significant differences between groups 
(P=0.39). Furthermore, HOMA-IS values from pre to 240 min post-exercise showed a significant decline within 
both the Indigenous (53.3 ± 7.3 %; P=0.007) and Caucasian (42.6 ± 5.2 %; P=0.03) groups, with no significant 
differences between groups (P=0.11) 
 
Discussion   
The findings demonstrate that despite being matched for VO2 and TB-FM %, Indigenous Australian and 
Caucasian groups varied in both baseline and post-exercise levels of some plasma inflammatory markers and 
glucose concentrations. Specifically, the younger Indigenous group had significantly higher fasting 
concentrations of glucose and TNF-α compared with the Caucasian group. Furthermore, although both groups 
showed an immediate post-exercise increase in anti-inflammatory markers (IL-6 and IL-1ra), the Caucasian 
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group sustained this elevated anti-inflammatory response longer than the Indigenous group. However, neither 
group showed any exercise-induced pro-inflammatory response (CRP, IL-1β and TNF-α). Collectively, these 
findings suggest an acute suppression of anti-inflammatory cytokines to standardised aerobic exercise in 
sedentary Indigenous men.  
 
A possible limitation in the present study is the recognised difference in chronological age between groups. 
However, when comparing chronological age between Indigenous and Caucasian populations, life expectancy is 
significantly different relative to their health status (Thomson and others, 2011). Therefore, matching of age 
does not provide a fair physiological comparison and can conflate the interpretation of the findings. For this 
reason the groups in the current study were matched for VO2 and TB-FM %, as these have a more salient 
influence on inflammatory markers and glucose regulation, rather than chronological age per se (Arsenault and 
others, 2009; Church and others, 2002). The present results show that younger, Indigenous men have high 
fasting glucose concentrations that are subsequently reflected in altered acute post-exercise responses compared 
to an older Caucasian group. Of concern, the Indigenous group were ~10.2 y younger than the Caucasians 
group, suggesting that the metabolic health of Indigenous Australians declines at an earlier age than Caucasian 
Australians. These higher fasting glucose concentrations, if evident over prolonged periods, can lead to the 
development of T2DM and associated co-morbidities (Thomson and others, 2011; Trewin and Madden, 2005). 
Interestingly, on a national scale the Indigenous Australian population have a known susceptibility to 
developing T2DM and CVD when compared to their Caucasian counterparts (Thomson and others, 2011; 
Trewin and Madden, 2005; Welfare, Cat no: IHW 42, 2011). While data from the current study is from a small 
sample size, it reiterates these differences in health status between Indigenous and Caucasian Australians. 
Furthermore, these data also highlight the need for targeted exercise interventions for young Indigenous 
Australians as a disease preventative approach and also to determine the causative mechanisms that underlie the 
poorer metabolic health of this group.  
 
Systemic inflammatory biomarkers are highly correlated with increased risk for chronic disease development 
and all-cause mortality (Koenig and others, 2008; Pradhan and others, 2001). Chronic elevation of TNF-α, IL-6 
and IL-1 from adipose tissue stimulates the nuclear factor-kappa beta pathway and regulates the hepatic release 
of CRP; in turn highlighting a causative role in the development of T2DM and CVD (Kahn and others, 2006). 
The present study showed no difference between groups in resting concentrations of IL-6, IL-1β or CRP. 
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However, in comparison to the Caucasian group, the Indigenous group had a significantly higher concentration 
of TNF-α and fasting glucose. Given the strong association of elevated TNF-α with impaired glucose control; 
higher TNF-α concentrations may provide reason for the observed baseline insulin resistance (>4 HOMA-IR) in 
the Indigenous group (Pedersen, 2011). Previous longitudinal studies have compared the health characteristics 
and effects of chronic exercise training between populations of differing ancestry (Miller and Cappuccio, 2007; 
Skinner and others, 2001). However, to date no evidence is available involving the acute physiological response 
to exercise for inflammatory and glucose markers between groups of differing ancestry.  
 
Markers indicative of a pro-inflammatory state (TNF-α, IL-1β, CRP) showed no significant exercise-induced 
responses; though, TNF-α remained elevated at all time-points in Indigenous compared to the Caucasian group. 
Moreover, in a rested state, increased IL-6 in the presence of elevated TNF-α is indicative of low-grade chronic 
systemic inflammation, whilst an exercise-induced increase of IL-6 in the absence of an elevated TNF-α is 
indicative of increased energy demand (Walsh and others, 2011). Though absent in the present study, an 
increase in TNF-α has been shown in response to strenuous prolonged exercise, with the magnitude potentially 
related to exercise duration and associated immunological parameters (Walsh and others, 2011).  Notably, CRP 
is reported to peak 24-48 h post-exercise, and represents one potential limitation of the current data that reports 
up to 240 min post-exercise (Pedersen and Febbraio, 2008). Despite this limitation, the present study shows that 
regardless of ancestry, neither group to have exercise-induced increases in pro-inflammatory markers, which 
may be attributable to the short duration, moderate intensity and/or the interval nature of the condition.   
 
Pro-inflammatory cytokines are suggested to be mediated by anti-inflammatory cytokines and cytokine 
inhibitors (e.g. cortisol), which can increase markedly in the circulation following prolonged exercise (Fischer, 
2006; Pedersen, 2011). Additionally, during strenuous exercise IL-6 has anti-inflammatory properties mediating 
skeletal muscle signalling processes via the activated protein kinase pathway (AMPK) and stimulating the 
expression of other anti-inflammatory cytokines, such as IL-1ra and IL-10 (Pedersen, 2011; Walsh and others, 
2011). Such increases of anti-inflammatory markers within the circulation may provide positive metabolic 
changes through increased fat oxidation and glucose uptake (Pedersen, 2006; Pedersen and Febbraio, 2008; 
Walsh and others, 2011). We observed that both groups increased anti-inflammatory cytokines IL-6 and IL-1ra 
immediately post-exercise. However, IL-6 remained elevated up to 60 min post-exercise and IL-1ra remained 
elevated up to 240 min post-exercise in the Caucasian group, but not the Indigenous group. This sustained 
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elevation of IL-6 and IL-1ra following exercise in the Caucasian group may partially explain the differences 
observed between groups in the pre to post-exercise glucose response. Similarly, since cortisol is a stimulatory 
hormone that contributes to increased hepatic glucose production (Kindermann and others, 1982), and IL-6 
stimulates peripheral glucose metabolism (muscle and adipose tissue) (Pedersen, 2006), the combined blunted 
cortisol response and increased IL-6 may explain the decreasing post-exercise plasma glucose levels in the 
Indigenous group. In contrast, the Caucasian group showed a pre to post increase in cortisol and glucose 
concentration, which may explain the sustained elevation of IL-6 following exercise (Steensberg and others, 
2001). Moreover, the higher pre-exercise glucose concentration in the Indigenous group may have accounted for 
the blunted cortisol response to the exercise condition. While speculative, the known metabolic contribution of 
cortisol (stimulate hepatic glucose production) during exercise could infer that the metabolic requirements to the 
same relative intensity was different between groups and thus had a substantial impact on the post-exercise anti-
inflammatory response. Given the small sample size and lack of previous literature, it is speculative to suggest 
there are ancestry dependent mechanisms responsible for these differences. However, it is suggested that the 
higher resting TNF-α and glucose concentrations within the Indigenous group may have contributed to the 
difference in post-exercise cortisol and anti-inflammatory responses between groups. 
 
In conclusion, despite being matched for VO2 and TB-FM %, there were differences in resting TNF-α and 
glucose concentrations between an Indigenous Australian and Caucasian group. This disparity at baseline may 
have contributed to different post-exercise anti-inflammatory responses (IL-6 and IL-1ra) between groups. The 
similar post-exercise (0-240 min) glucose response between groups highlights the value of acute moderate-
intensity exercise to be completed daily to assist with long-term improvements in glucose, irrespective of 
ancestry. Of note, the results of the current study suggest it to be even more pertinent for exercise to be 
encouraged within the Indigenous Australian population due to their elevated resting glucose levels at a younger 
age, when compared to the respective Caucasian group. Furthermore, exercise prescription within high-risk 
Indigenous populations should be designed to specifically focus on risk stratification, cultural sensitivity and 
thus ensure appropriate adaptations to exercise for chronic disease prevention. Whilst the outcomes of the 
current study are specific to Indigenous Australians and Caucasians, the findings highlight the need for 
additional research on exercise prescription involving acute differences within and between other Indigenous 
populations at high-risk of metabolic abnormalities. 
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Figure Legends 
Fig. 1. 
Mean ± SEM response of IL-6, IL-1ra, CRP, TNF-α and IL-1β within and between the respective groups. 
 
a
 Significant change within the Indigenous group (P<0.05); 
b
 Significant change within the Caucasian group 
(P<0.05); 
c
 Significant difference between groups (P<0.05); 
d
 Pre to 240 min change significantly different in 
both groups (P<0.05) 
Fig. 2. 
Mean ± SEM response of cortisol, glucose and insulin within and between the respective groups.  
a
 Significant change within the Indigenous group (P<0.05); 
b
 Significant change within the Caucasian group 
(P<0.05); 
c
 Significant difference between groups (P<0.05); 
d
 Pre to 240 min change significantly different in 
both groups (P<0.05) 
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Table 1. 
Mean ± SEM Baseline characteristics, body composition and fasting 
blood chemistry of Indigenous and Caucasian participants.  
 
Variable 
Indigenous 
(n=10) 
Caucasian 
(n=9) 
Age (y)
 a
 38.5 ± 3.2 48.8 ± 1.7 
Height (cm) 177.7 ± 3.1 177.4 ± 1.8 
Mass (kg) 101.5 ± 7.9 101.9 ± 3.3 
BMI (kg
.
m
2
) 31.9 ± 2.0 32.3 ± 0.9 
Sub-maximal VO2 (mL
.
kg
-1.
min
-1
) 30.8 ± 1.7 30.8 ± 1.3 
Systole blood pressure (mmHg) 131 ± 3 131 ± 4 
Diastole blood pressure (mmHg) 84 ± 2 82 ± 1.9 
Waist circumference (cm) 103.6 ± 5.9 107.0 ± 2.5 
WHR 0.95 ± 0.03 0.99 ± 0.02 
Total Body – Fat Mass (%) 27.8 ± 3.6 31.4 ± 1.6 
Intra-Abdominal Fat Mass (kg) 3.56 ± 0.7 3.57 ± 0.29 
Total cholesterol (mmol
.
L
-1
) 5.1 ± 0.3 5.8 ± 0.4 
HDL (mmol
.
L
-1
) 1.1 ± 0.1 1.3 ± 0.1 
Triglycerides (mmol
.
L
-1
) 1.6 ± 0.2 2.2 ± 0.4 
Hazard ratio (Total : HDL) 4.8 ± 1.5 4.6 ± 0.4 
HbA1c (%A1c) 5.7 ± 0.2 5.7 ± 0.1 
Glucose (mmol
.
L
-1
) 
a
 5.4 ± 0.2 4.6 ± 0.9 
Insulin (µlU
.
mL
-1
) 17.7 ± 4.6 11.5 ± 2.9 
Insulin resistance (HOMA-IS) 4.4 ± 1.2 2.4 ± 0.6 
Total Leukocyte Count (10
-9.
L
-1
) 6.9 ± 0.6 6.1 ± 0.4 
Cortisol (nmol
.
L
-1
) 400.8 ± 34.5 463.9 ± 43.6 
CRP (mg
.
L
-1
) 3.3 ± 0.8 3.0 ± 0.7 
IL-6 (pg
.
mL
-1
) 1.0 ± 0.2 1.4 ± 0.3 
TNF-α (pg.mL-1) 
a
 2.6± 0.4 1.2 ± 0.2
 
 
IL-1ra (pg
.
mL
-1
) 252.6 ± 27.9 235.2 ± 24.3 
IL-1β (pg.mL-1) 1.42 ± 0.11 1.6 ± 0.1 
 
BMI = Body mass index; VO2 = Oxygen Consumption; WHR = Waist to hip ratio;  
HDL = High density lipoprotein; CRP = C-reactive protein;  
IL = interleukin; ra = receptor agonist; TNF = Tumor necrosis factor.  
a
 Significant difference between groups (P<0.05)  
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